CABG vs. PCI for Unprotected Left Main Coronary Artery Disease

Medical guidelines in the United States and Europe endorse coronary artery bypass grafting (CABG) as the preferred revascularisation strategy over percutaneous coronary intervention (PCI) for patients with left main coronary artery (LMCA) disease.

The preference for CABG is based on evidence showing reductions in repeat revascularisation and myocardial infarction. However, a consistent mortality benefit has not been demonstrated when comparing the two strategies.

Clinical Risks of Left Main Disease

Obstructive unprotected left main (ULM) disease is identified as a high-risk condition. If not treated promptly, this anatomical subset of coronary disease can result in poor clinical outcomes.

For several decades, CABG was advocated as the first-line therapy for these patients. Over time, the outcomes of percutaneous coronary interventions have improved, supported by widespread technological advancements.

Evidence from Major Clinical Trials

The NOBLE trial provided significant data on this comparison, reporting that CABG was superior to PCI in 1,201 subjects over a follow-up period of up to five years.

To address limitations found in previous trials, the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularisation) trial was conducted. The EXCEL trial included nearly 2,000 participants, which nearly doubled the total number of participants in prior trials analyzing PCI and CABG in LMCA disease.

Further analysis has been conducted to determine long-term impacts. This includes an updated meta-analysis of randomized trials using reconstructed individual-participant survival data to examine long-term mortality after PCI or CABG for left main stem disease.

Evolution of Treatment Nuance

A comment published in The Lancet on April 4, 2026, notes that there is more nuance in left main revascularisation ten years after the NOBLE trial.

This evolving perspective considers the established advantages of CABG in reducing myocardial infarction and the necessity for repeat procedures, while acknowledging the improved outcomes associated with modern PCI techniques.